Resolution Therapeutics

Series-B+
resolution-tx.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Series-B+
Last Announced Oct 3, 2024
Investors Undisclosed
Decision Makers 6 Verified

About Resolution Therapeutics

Resolution Therapeutics is a clinical stage biotech company pioneering macrophage cell therapy for the treatment of end stage liver disease.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website resolution-tx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @ResolutionTx (57 followers) Created on Nov 2023
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  2. Milestone

    X account created (@ResolutionTx)

    57 followers

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Resolution Therapeutics.

Funding History

1 Round
Series-B+ · Oct 3, 2024

Founders & Leadership

1

Philip Starkey Lewis

Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts